American scientists Award

  “Bio-Economy and Space Economy are going to spearhead India’s future growth story” says Union Minister Dr Jitendra Singh at the launch of ‘Impact Report 2024’ on National Biopharma Mission at the National Biopharma Mission Conclave celebrating its 5 years journey at the Dr. Ambedkar International Centre, New Delhi. Union Minister of State (Independent Charge) for Science and Technology, Dr Jitendra Singh recalled the journey of National Biopharma Mission since its inception along with Biotechnology Industry Research Assistance Council (BIRAC) “National Biopharma Mission (NBM) is Celebrating 5 Years of Pioneering Success” and called it a milestone. The National Biopharma Mission (NBM)- Innovate in India (I3) is an Industry-Academia Collaborative Mission for Accelerating Discovery Research for development of Biopharmaceuticals. BIRAC has the mandate to enable and nurture an ecosystem for preparing India’s technological and product development capabilities in bio pharmaceuticals,

The human brain is an engineering marvel: 86 billion neurons form some 100 trillion connections to create a network so complex that it is, ironically, mind boggling. This week scientists published the highest-resolution map yet of one small piece of the brain, a tissue sample one cubic millimeter in size. The resulting data set comprised 1,400 terabytes. (If they were to reconstruct the entire human brain, the data set would be a full zettabyte. That’s a billion terabytes. That’s roughly a year’s worth of all the digital content in the world.) This map is just one of many that have been in the news in recent years. (I wrote about another brain map last year.) So this week I thought we could walk through some of the ways researchers make these maps and how they hope to use them. Scientists have been trying to map the brain for as long as they’ve been studying it. One of the most well-known brain maps came from German anatomist Korbinian Brodmann. In the early 1900s, he took section

Neurodegenerative diseases occur when nerve cells in the brain and peripheral nervous system lose function and eventually die. They include Alzheimer’s disease, Parkinson’s disease , and amyotrophic lateral sclerosisTrusted Source (ALS — also known as motor neuron disease), among othersTrusted Source In the United States, an estimated 6.9 million people aged 65 and over are living with Alzheimer’s disease, and around a million have Parkinson’s. ALS is less common; the CDC estimates that around 31,000 peopleTrusted Source in the U.S. have the condition. Current treatments can alleviate symptoms and some slow the progression of the diseases, but no cures are yet available. New monoclonal antibody treatments for Alzheimer’s have shown some potential for modifying the course of the disease, but many experts are concerned about side effects. In the search for new therapies, research from Penn State University has identified a group of proteins that could be a target for new treatments f

A new report makes the strong case that a class of industrial chemicals called endocrine disruptors are behind many diseases on the rise globally. The report calls for stronger global regulations controlling their use and release into the environment. A joint effort by the Endocrine Society and the International Pollutants Elimination Network (IPEN), the report includes fresh research from the past decade documenting evidence that endocrine-disrupting chemicals (EDCs) contribute to reproductive disorders, cancer, diabetes, obesity, heart disease, neurological conditions, reduced immune function, chronic inflammation, and other serious health conditions. Research shows the chemicals to be especially dangerous to pregnant women and to children. Endocrine disruptors interfere with natural human hormones and disrupt the smooth functioning of the endocrine system, which governs everything from fetal development and fertility to skin appearance, metabolism, and immune function. Some endo